79 related articles for article (PubMed ID: 24962950)
21. Does an Apple a Day Also Keep the Microbes Away? The Interplay Between Diet, Microbiota, and Host Defense Peptides at the Intestinal Mucosal Barrier.
Puértolas-Balint F; Schroeder BO
Front Immunol; 2020; 11():1164. PubMed ID: 32655555
[TBL] [Abstract][Full Text] [Related]
22. Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis.
Maletzki C; Klier U; Marinkovic S; Klar E; Andrä J; Linnebacher M
Oncotarget; 2014 Jun; 5(12):4467-79. PubMed ID: 24962950
[TBL] [Abstract][Full Text] [Related]
23. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
[TBL] [Abstract][Full Text] [Related]
24. Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model.
Steinstraesser L; Hauk J; Al-Benna S; Langer S; Ring A; Kesting M; Sudhoff H; Becerikli M; Käfferlein H; Jacobsen F
Drug Chem Toxicol; 2012 Jan; 35(1):96-103. PubMed ID: 21851146
[TBL] [Abstract][Full Text] [Related]
25. Design of NK-2-derived peptides with improved activity against equine sarcoid cells.
Gross S; Wilms D; Krause J; Brezesinski G; Andrä J
J Pept Sci; 2013 Oct; 19(10):619-28. PubMed ID: 23893605
[TBL] [Abstract][Full Text] [Related]
26. Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomas.
Maletzki C; Stier S; Gruenert U; Gock M; Ostwald C; Prall F; Linnebacher M
PLoS One; 2012; 7(12):e52485. PubMed ID: 23300683
[TBL] [Abstract][Full Text] [Related]
27. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation.
Banković J; Andrä J; Todorović N; Podolski-Renić A; Milošević Z; Miljković D; Krause J; Ruždijić S; Tanić N; Pešić M
Exp Cell Res; 2013 Apr; 319(7):1013-27. PubMed ID: 23298945
[TBL] [Abstract][Full Text] [Related]
28. Anticancer peptide NK-2 targets cell surface sulphated glycans rather than sialic acids.
Gross S; Andrä J
Biol Chem; 2012 Aug; 393(8):817-27. PubMed ID: 22944683
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of acquired resistance to targeted cancer therapies.
Lackner MR; Wilson TR; Settleman J
Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
[TBL] [Abstract][Full Text] [Related]
30. Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies.
Ray S; Langan RC; Mullinax JE; Koizumi T; Xin HW; Wiegand GW; Anderson AJ; Stojadinovic A; Thorgeirsson S; Rudloff U; Avital I
J Cancer; 2012; 3():196-206. PubMed ID: 22606209
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic activities of host defense peptides.
Al-Benna S; Shai Y; Jacobsen F; Steinstraesser L
Int J Mol Sci; 2011; 12(11):8027-51. PubMed ID: 22174648
[TBL] [Abstract][Full Text] [Related]
32. Online monitoring of metabolism and morphology of peptide-treated neuroblastoma cancer cells and keratinocytes.
Drechsler S; Andrä J
J Bioenerg Biomembr; 2011 Jun; 43(3):275-85. PubMed ID: 21643697
[TBL] [Abstract][Full Text] [Related]
33. Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide.
Steinstraesser L; Hauk J; Schubert C; Al-Benna S; Stricker I; Hatt H; Shai Y; Steinau HU; Jacobsen F
PLoS One; 2011 Mar; 6(3):e18321. PubMed ID: 21483840
[TBL] [Abstract][Full Text] [Related]
34. Oncolytic designer host defense peptide suppresses growth of human liposarcoma.
Steinstraesser L; Schubert C; Hauk J; Becerikli M; Stricker I; Koeller M; Hatt H; von Duering M; Shai Y; Steinau HU; Jacobsen F
Int J Cancer; 2011 Jun; 128(12):2994-3004. PubMed ID: 20734391
[TBL] [Abstract][Full Text] [Related]
35. Cryopreservation of human colorectal carcinomas prior to xenografting.
Linnebacher M; Maletzki C; Ostwald C; Klier U; Krohn M; Klar E; Prall F
BMC Cancer; 2010 Jul; 10():362. PubMed ID: 20615215
[TBL] [Abstract][Full Text] [Related]
36. A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells.
Chen YQ; Min C; Sang M; Han YY; Ma X; Xue XQ; Zhang SQ
Peptides; 2010 Aug; 31(8):1504-10. PubMed ID: 20493915
[TBL] [Abstract][Full Text] [Related]
37. The global burden of cancer: priorities for prevention.
Thun MJ; DeLancey JO; Center MM; Jemal A; Ward EM
Carcinogenesis; 2010 Jan; 31(1):100-10. PubMed ID: 19934210
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
